Navigation Links
Screening mammograms catch second breast cancers early
Date:2/22/2011

More women are surviving longer after having early-stage breast cancer, but they are at risk of developing breast cancer again: a recurrence or a new cancer, in either breast. Annual screening (a.k.a. "surveillance") mammography has long been standard for these women, but only scant evidence on screening outcomes supported this practice. In the February 23, 2011 Journal of the American Medical Association, the most comprehensive relevant study to date shows yearly mammograms do detect second breast cancers early.

The Breast Cancer Surveillance Consortium (BCSC) study examined 12 years of information from 58,870 screening mammograms in 19,078 women who had had early-stage breast cancerand an equal number of screening mammograms in 55,315 women who had no such history and were matched for breast density, age, BCSC registry, and year of mammography.

With her BCSC colleagues, Nehmat Houssami, MBBS, PhD, an associate professor at the University of Sydney's School of Public Health and Sydney Medical School and a physician at the Royal Hospital for Women, in Australia, found that women with a personal history of breast cancer had double the cancer rates as those with no such history. Women who had had breast cancer had 655 second cancers within a year of screening mammography, and those with no prior breast cancer had 342 cancers, with cancer rates of 10.5 vs. 5.8 per 1,000 screens, respectively.

"The comprehensive data from the BCSC made it possible for us to carefully examine the outcomes of screening for both the previously affected (conserved) breast, as well as the opposite breast, at a population level," Dr Houssami said. "This is the first study in the world, to our knowledge, to provide a complete picture of the expected outcomes of mammography screening for women with a personal history of breast cancer."

"Mammography was effective at finding cancers early in women who had had cancer, but not quite as effective as in those who had not," Dr. Houssami said, "We found that both false positives and 'interval cancers' were higher, and mammography was not as sensitive at detecting invasive breast cancer, in women with a personal history of breast cancer." False positives mean that a mammogram suggests a breast cancer may be present, but after further testing it turns out not to be. Interval cancers are breast cancers that were not detected on screening mammography and are found between mammography screens, prompted by either breast symptoms or additional testing.

"Because of the risk of interval cancers, it's important that women seek medical care for any breast changes or concerns between mammograms," said Dr. Houssami's collaborator Diana Miglioretti, PhD, a senior investigator at Group Health Research Institute. "The good news is that most of the breast cancers detected in breast cancer survivors between mammography screens were early stage."

Interval-cancer rates were particularly high in women who were younger than 50, had extremely dense breasts, or received breast-conserving treatment (lumpectomy) without radiotherapy for their first cancer. "Our results suggest that we should consider more tailored screening strategies in these women, such as additional or alternate screening modalities in some groupsbut this needs further research," Dr. Miglioretti said.


'/>"/>

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute
Source:Eurekalert  

Related medicine news :

1. Higher volume reduces false positives in screening mammography
2. Worlds largest lung cancer screening conference to address benefits of CT scans
3. Breast cancer screening with MRI benefits women with radiation therapy history
4. Screening for cervical cancer low for immigrant women
5. Repeat MRI screening for breast cancer results in fewer false positives
6. Study finds MRSA screening saves hospitals money
7. More Screenings May Explain Higher Chlamydia Rates Among Minorities
8. Biodesign hosts international consortium on screening for lung cancer
9. Predeployment Mental Health Screening May Help Troops
10. New Osteoporosis Screening Recommendations Issued
11. Geography May Influence Colon Cancer Screening Rates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Screening mammograms catch second breast cancers early
(Date:1/22/2017)... , ... January 22, 2017 , ... Zifam Pinnacle, an ... the world, recently met with big-name retail buyers at the January ECRM Trade Show ... efficacy and uses the utmost safety standards in all of its creations to help ...
(Date:1/21/2017)... FL (PRWEB) , ... January 21, 2017 , ... Caronlab ... recently attended the January ECRM Trade Show in Hilton Head, SC, where it benefited ... reputation for the quality of its beauty and wellness products. At this trade show, ...
(Date:1/21/2017)... ... 21, 2017 , ... Seamild, the largest manufacturer of oats in China, is ... and founder. As Oat is recognized globally as one of the healthiest cereals, XieQingkui, ... believes it is a move to sow the seed of good karma. Buddhism spirit ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical Associates (NCMA) ... their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, ... add this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast ... ... Sales Volume, Company Analysis and Forecast to 2022 provides a ... The growing prevalence of hearing impairment coupled with an ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Pharmaceuticals Inc. (NASDAQ: SGYP ), Novo Nordisk A/S ... SCMP ), and Pernix Therapeutics Holdings Inc. (NASDAQ: ... which fell on Thursday, January 19 th , 2017, finishing ... NYSE Health Care Index dropped over 0.7%, while shares of ...
Breaking Medicine Technology: